Madison Avenue Securities shows up on BrokerCheck beside a pending customer arbitration naming Wesley Palmer (CRD 6433982). The product at issue is a BDC or interval fund. The allegations are unproven, and no party has paid anything on the claim.

The Financial Industry Regulatory Authority (“FINRA”) shows that investors disputed the sales practices of Ameriprise Financial Services Inc. securities broker Bill Utanski (CRD#: 2576809, Fort Lauderdale, Florida). Notably, since January 15, 2015, four investors brought complaints or FINRA Arbitrations suggesting Utanski made unsuitable investments. Here is a summary of those disputes:
An investor who held accounts with Ameriprise Financial Services filed a compliant on June 1, 2017 regarding Utanski. Supposedly, Utanski advised the client to buy risky OTC stocks. Those recommendations were not appropriate, according to the client’s attorney. Supposedly, the client sustained losses from holding the speculative OTC stocks. For this reason, on August 7, 2017, Ameriprise Financial Services opted to settle the matter by compensating the client for the losses.
The second most recent complaint comes from an Ameriprise investor who suggested Utanski made “one-size-fits-all” recommendations. The complaint, brought December 4, 2015, alleges that Utanski advised the client to hold a large position in Dendreon Corporation (Seattle, Washington). By following Utanski’s advice, the client’s account apparently ended up overconcentrated in this stock. Eventually, Dendreon filed for Chapter 11 bankruptcy protection following disappointing results on the company’s cancer vaccine. When news of the bankruptcy broke, Dendreon’s shares, which peaked in April 2010 at $57.67 per share, plummeted to less than a quarter per share. Evidently, Ameriprise Financial Services compensated this client for losses.
Utanski reports that a third Ameriprise Financial Services Inc. client took aim at his sales practices. Apparently, the client brought FINRA Arbitration #: 15-02629 on November 10, 2016. First of all, the client suggested that Utanski gave unreasonable investment advice regarding the client’s purchase of Dendreon stock. Secondly, Utanski allegedly churned the client’s investments. As a result, on November 10, 2016, Ameriprise Financial Services Inc. agreed to pay the client $20,000 to put the claim to rest.
Evidently, the first Ameriprise Financial Services Inc. to file a dispute about Bill Utanski brought FINRA Arbitration #: 15-00076 on January 15, 2015. In the Statement of Claim, the client alleged unsuitable recommendations and misrepresentation. Namely, Utanski potentially advised the client to buy 10,000 shares in Dendreon Corporation. This advice was supposedly unsuitable because the risks of the investments exceeded the client’s risk tolerance. Also, the client suggested that Utanski personally guaranteed he principal invested in Dendreon Corporation. Allegedly, Utanski told the client that he would repay her if she incurred losses on the investment. It appears that Ameriprise settled this dispute by paying the client $100,000.

Suffered losses by investing with broker Bill Utanski? If so, contact Soreide Law Group at (888) 760-6552 and speak with experienced counsel about a possible recovery of your investment losses. Soreide Law Group represents clients on a contingency fee basis and advances all costs. The firm has recovered millions of dollars for investors who have suffered losses due to misconduct of brokers and brokerage firms.
Madison Avenue Securities shows up on BrokerCheck beside a pending customer arbitration naming Wesley Palmer (CRD 6433982). The product at issue is a BDC or interval fund. The allegations are unproven, and no party has paid anything on the claim.
FINRA entered findings against Matt Ward (CRD 2075525) over his trading authority in customer accounts. He consented without admitting or denying them. BrokerCheck also lists settled customer disputes at Alliance Global Partners and Euro Pacific Capital.
A variable annuity and life insurance are the products in a pending claim against Deborah Key (CRD 1236421). Its allegations are unproven, and no money has been paid on it.
Phone:
Fax: 1-954-760-6553
Email: [email protected]